Lv31
220 积分 2025-07-16 加入
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines
2个月前
已完结
Optimization of SEC-HPLC Method for the Quantitative Estimation of a Process-Related Residual Impurity, Dimethylaminopyridine (DMAP) in the Manufacturing of Pneumococcal Polysaccharide Conjugates Vaccine
3个月前
已完结
The vaccine dosing effect overcomes the reduced immunogenic potential and in vivo efficacy of 33F pneumococcal serotype
3个月前
已完结
Structural validation and immunogenic characterization of Streptococcus pneumoniae serotype 22A capsular polysaccharide relative to serotype 22F
4个月前
已完结
Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial
8个月前
已完结
Chemical technology principles for selective bioconjugation of proteins and antibodies
10个月前
已完结
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
10个月前
已完结
Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges
1年前
已完结
Purification of capsular polysaccharides isolated from S. pneumoniae serotype 2 by hydrogen peroxide and endonuclease
1年前
已完结
皖公网安备34019202002308
